Meta-analysis of Randomized Trials Acute ST-Segment Elevation Myocardial Infarction: A Abciximab as Adjunctive Therapy to Reperfusion in Correction
نویسندگان
چکیده
Correction Contact me if this article is corrected. Citations Contact me when this article is cited. This article has been cited 124 times. Topic collections Contact me when new articles are published in these topic areas. Myocardial Infarction; Cardiovascular Intervention Vascular Surgery; Review; Randomized Controlled Trial; Cardiovascular Disease/ Medicine; Surgery; Surgical Interventions; Cardiovascular/ Cardiothoracic Surgery; Revascularization; Cardiovascular System; Quality of Care; Evidence-Based
منابع مشابه
Coronary bioabsorbable magnesium stent: 15-month intravascular ultrasound and optical coherence tomography findings.
Gupta N. Importance of time-to-reperfusion in patients with acute myocardial infarction with and without cardiogenic shock treated with primary percutaneous coronary intervention. Am Heart J 2003;145: 708–715. 26. De Luca G, Suryapranata H, Stone GW, Antoniucci D, Tcheng JE, Neumann FJ, Van de Werf F, Antman EM, Topol EJ. Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevat...
متن کاملAbciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials.
CONTEXT The benefits of abciximab in patients with ST-segment elevation myocardial infarction (STEMI) are still a matter of debate. OBJECTIVE To combine data from all randomized trials conducted with abciximab in STEMI. DATA SOURCES Formal searches of electronic databases (MEDLINE, PubMed) from from January 1990 to December 2004. STUDY SELECTION We examined all completed, published, rando...
متن کاملIntracoronary versus intravenous abciximab in ST-segment elevation myocardial infarction: rationale and design of the CICERO trial in patients undergoing primary percutaneous coronary intervention with thrombus aspiration
BACKGROUND Administration of abciximab during primary percutaneous coronary intervention is an effective adjunctive therapy in the treatment of patients with ST-segment elevation myocardial infarction. Recent small-scaled studies have suggested that intracoronary administration of abciximab during primary percutaneous coronary intervention is superior to conventional intravenous administration....
متن کاملA comparison of abciximab and small-molecule glycoprotein IIb/IIIa inhibitors in patients undergoing primary percutaneous coronary intervention: a meta-analysis of contemporary randomized controlled trials.
BACKGROUND Current guidelines recommend abciximab as the preferred agent for patients undergoing primary percutaneous coronary intervention, yet small-molecule glycoprotein IIb/IIIa inhibitors are more commonly used in clinical practice. The objective of our meta-analysis was to evaluate for differences in clinical outcome between small-molecule glycoprotein IIb/IIIa inhibitors and abciximab in...
متن کاملAdjunctive thrombectomy for acute myocardial infarction: A bayesian meta-analysis.
BACKGROUND In available trials and meta-analyses, adjunctive thrombectomy in acute myocardial infarction (MI) improves markers of myocardial reperfusion but has limited effects on clinical outcomes. Thrombectomy devices simply aspirate thrombus or mechanically fragment it before aspiration. Simple aspiration thrombectomy may offer a distinct advantage. METHODS AND RESULTS We identified 21 eli...
متن کامل